Amgen (AMGN) Boosts Buyback by $2B
Amgen, Inc. (NASDAQ: AMGN) approved an increase in share repurchase authorization in the amount of $2 billion. This amount is in addition to approximately $0.5 billion remaining under the previously announced $10 billion share repurchase program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Chevron (CVX) Suspends Share Buyback for 2015, Says CFO
- Polaris Industries (PII) Raises Quarterly Dividend 10.4% to $0.53; Adds 4M Common to Buyback
- Roth Remains Positive on Ligand (LGND) Following Kyprolis Q4 Sales Data, sNDA Filing (AMGN)
Create E-mail Alert Related CategoriesHot Buybacks, Stock Buybacks
Related EntitiesStock Buyback
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!